http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Diana M. Hernández-Corona (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Diana M. Hernández-Corona,Esperanza Martínez-Abundis,Manuel González-Ortiz 한국식품영양과학회 2014 Journal of medicinal food Vol.17 No.7
The aim of this article is to evaluate the effect of fucoidan administration on insulin secretion and insulin sensitivity in overweight or obese adults. A randomized, double-blind, placebo-controlled clinical trial was carried out in 25 obese or overweight volunteers. Thirteen patients received an oral dose of 500 mg of fucoidan once daily before breakfast and 12 patients received placebo for 3 months. Before and after the intervention, fasting glucose and 2-h postload, total cholesterol, high-density lipoprotein cholesterol, triglycerides, and insulin levels were measured. Low-density lipoprotein cholesterol (LDL-C) and homeostasis model analysis formulas (HOMA) for b-cell function and insulin resistance were calculated. The results showed a significant decrease in diastolic blood pressure (71.7 – 12.2 vs. 67.8 – 13.8 mmHg; P < .05) and LDL-C (3.1 – 0.5 vs. 2.7 – 0.6 mmol/l; P < .01) with increase in insulin levels (60.6 – 24.0 vs. 78.6 – 32.4 pmol/l; P < .05), HOMA b-cell (35.0 – 20.8 vs. 50.6 – 18.7; P < .05) and HOMA IR (1.9 – 1.2 vs. 2.6 – 1.8; P < .05) were observed after fucoidan administration. We conclude that fucoidan administration during a 3-month period in overweight or obese adults decreased diastolic blood pressure and LDL-C concentrations, increasing insulin secretion and insulin resistance.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
